Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure

Clinical Science

Volumn 103, Issue SUPPL. 48, 2002, Pages

  Ohnishi, Masato ^a   Wada, Atsuyuki ^a   Tsutamoto, Takayoshi ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Yamamoto, Takashi ^a   Takayama, Tomoyuki ^a   Wang, Xinwen ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Dog; Endothelin; Heart failure; Nitric oxide; Nitric oxide synthase

Indexed keywords

ARGININE DERIVATIVE; DIMETHYLARGININE; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; N [6 [2 (5 BROMO 2 PYRIMIDINYLOXY)ETHOXY] 5 (4 METHYLPHENYL) 4 PYRIMIDINYL] 4 (2 HYDROXY 1,1 DIMETHYLETHYL)BENZENESULFONAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL TONE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; HEART OUTPUT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULAR RESISTANCE; VASODILATATION;

EID: 0036671662     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs103s241s     Document Type: Conference Paper

References (25)

1. Alteration in vasomotor tone in congestive heart failure
2. The vascular endothelium in chronic renal failure
3. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
4. Integrated cardiac, renal, and endocrine actions of endothelin
5. Relation between endothelin-1 spillover in the lungs and the pulmonary vascular resistance in patients with chronic heart failure
6. A and ETB receptor antagonists in congestive heart failure
7. B receptor antagonist in heart faillure
8. Nitric oxide: Physiology, pathophysiology, and pharmacology
9. Endothelium-dependent vasodilation is attenuated in patients with heart failure
10. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure
11. Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure
12. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptides in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase coupled receptor
13. Asymmetric dimethylarginine, an endogenous nitric oxid synthase inhibitor, in experimental hypertension
14. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure
15. Heart failure depresses endothelium-dependent responses in canine femoral artery
16. Depressed beta-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure
17. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure
18. Endothelin induces NAD(P)H oxidase in human endothelial cells
19. Oxidative stress and heart failure
20. Elevation of an endogeneous inhibitor of nitric oxide synthesis in experimental congestive heart failure
21. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis
22. G-monomethyl-L-arginine uptake: A mechanism for differential inhibition of NO systhases?
23. Increased L-arginine transport in human erythrocytes in chronic heart failure
24. Chronic heart failure activates the L-arginine-nitric oxide signalling pathway in human peripheral blood mononuclear cells
25. Role of L-arginine - Endogenous NOS inhibitors - Endothelin-1 pathway for the vascular remodelling